Pharmaust Limited

ASX:PAA ISIN:AU000000PAA1

PharmAust LtdPharmAust specialises in the relaunch of existing marketed products for oncology applications making the whole development, regulatory and commercialisation process much faster. In addition, PharmAust's other wholly owned subsidiary, Epichem Pty Ltd generates sales of around $1.7M per annum from contract sales to the pharmaceutical industry of synthetic drugs.

 
    
          

View in Other Languages

News

ADX Energy Limited (ASX:ADX) Lambouka-1 Well Operations Update #7

🕔8/24/2010 3:58:03 PM 5517

ADX Energy Limited (ASX:ADX) (PINK:ADXRF) reports on Lambouka-1 Well operations update.

Read Full Article

ADX Energy Limited (ASX:ADX) Lambouka-1 Operation Update

🕔8/19/2010 1:58:44 PM 5116

ADX Energy Ltd (ASX:ADX) (PINK:ADXRF) advises that the Lambouka-1 well has intersected the complete Ain Grab section encountering porous reservoir sandstone as prognosed. However the section is interpreted to be water bearing based on MWD (measurement while drilling) logs. The Ain Grab was considered a secondary target in the Lambouka-1 well.

Read Full Article

ADX Energy Limited (ASX:ADX) Lambouka-1 Well Operations Update #6

🕔8/17/2010 3:57:43 PM 3384

ADX Energy Limited (ASX:ADX) (PINK:ADXRF) reports on Lambouka-1 Well operations update.

Read Full Article

ADX Energy Limited (ASX:ADX) Results from the First Target Formation At The Lambouka-1 Well

🕔8/16/2010 10:57:56 AM 3749

ADX Energy Limited (ASX:ADX) (PINK:ADXRF) advises that the Lambouka-1 has encountered the first Birsa sandstone formation at a measured depth of 1,635 meters.

Read Full Article

ADX Energy Limited (ASX:ADX) Lambouka-1 Well Operations Update #5

🕔8/10/2010 1:19:24 PM 5008

ADX Energy Limited (ASX:ADX) (PINK:ADXRF) reports on Lambouka-1 Well operations update.

Read Full Article

ADX Energy Limited (ASX:ADX) Lambouka-1 Well Operations Update #4

🕔8/3/2010 4:14:52 PM 5037

ADX Energy Limited (ASX:ADX) (PINK:ADXRF) reports on Lambouka-1 Well operations update.

Read Full Article

ADX Energy Limited (ASX:ADX) Lambouka-1 Well Operations Update #3

🕔7/27/2010 2:25:53 PM 7326

ADX Energy Limited (ASX:ADX) (PINK:ADXRF) reports on Lambouka-1 Well operations Update.

Read Full Article

ADX Energy Limited (ASX:ADX) Lambouka-1 Well Operations Update #2

🕔7/20/2010 2:01:06 PM 6348

ADX Energy Limited (ASX:ADX) (PINK:ADXRF) updates Lambouka-1 Well operations.

Read Full Article

ADX Energy Limited (ASX:ADX) Lambouka-1 Well Operations Update #1

🕔7/13/2010 12:01:10 PM 5112

ADX Energy Limited (ASX:ADX) updates Lambouka-1 well operations. Since arrival at the Lambouka-1 well location on July 2, the Southern Cross Semi Submersible drilling rig was positioned and anchored.

Read Full Article

ADX Energy Limited (ASX:ADX) Spuds Lambouka-1 Exploration Well Offshore Tunisia

🕔7/12/2010 9:08:37 AM 5071

ADX Energy Ltd (ASX:ADX) is pleased to announce that on the 11th of July 2010 at 11.40 am GMT the Atwood Southern Cross semisubmersible drilling rig spudded the Lambouka-1 well in the ADX operated Kerkouane license in the Sicily Channel area offshore Tunisia.

Read Full Article
###

122,728 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 27) (Last 30 Days: 176) (Since Published: 19696) 

Company Data

    Headquarters
  • Suite 39, 1 Freshwater Parade
    Claremont WA 6010
    Australia
  • Telephone
  • +61 (8) 9202 6814 
  • Fax
  • +61 8 9467 6111 
  • Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Biotechnology 
  • Listed
  • 2001/10/05 
  • Homepage
  • www.pharmaust.com
  • E:
  • rogeraston@pharmaust.com

More News Results

  • 2024/05/09: Cleansing Notice*
  • 2024/05/09: Application for quotation of securities - PAA*
  • 2024/05/09: Board Changes*
  • 2024/05/07: Trading Halt*
  • 2024/04/30: Appendix 4C & Quarterly Update*
  • 2024/04/23: Resignation of Dr Michael Thurn & appointment of John Clark*
  • 2024/04/19: Cleansing Notice*
  • 2024/04/19: Application for quotation of securities - PAA*
  • 2024/04/18: PharmAust makes Head of Manufacturing appointment*
  • 2024/04/10: Final Ethics Approval for Open-Label MND Extension Study*
*refer to company website

Social Media